Global Conductive Polymers Market Report 2025-2035: Increasing Demand Across Electronics, Energy Storage, and EMI Shielding Applications – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “The Global Conductive Polymers Market 2025-2035” report has been added to ResearchAndMarkets.com’s offering.... Read more.
Hope Bancorp Declares Quarterly Cash Dividend of $0.14 Per Share
LOS ANGELES–(BUSINESS WIRE)–Hope Bancorp, Inc. (the “Company”) (NASDAQ: HOPE) today announced that its Board of Directors declared a quarterly cash... Read more.
Arkose Labs Expands Strategic Relationship with Microsoft, Including Expanding Its Services to Microsoft Azure
Arkose Labs’ and Microsoft’s development efforts, collaboration and shared investment thrive to provide innovative account security experience across Microsoft... Read more.
Vestis Announces Date for Fiscal Second Quarter 2025 Earnings Results
ATLANTA–(BUSINESS WIRE)–Vestis (NYSE: VSTS), a leading provider of uniforms and workplace supplies, has announced that it will report its fiscal second... Read more.
Owens Corning Publishes 2024 Sustainability Report
TOLEDO, Ohio–(BUSINESS WIRE)–Owens Corning (NYSE: OC) today published its 2024 Sustainability Report, Building Better Together, outlining the company’s... Read more.
Caliber Gains Approval for Canyon Village Redevelopment
Unanimous Phoenix City Council vote paves way for distressed office conversion to multifamily residential SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#alternativeassets—Caliber... Read more.
Driven Brands Holdings Inc. to Host First Quarter Earnings Call on May 6, 2025
CHARLOTTE, N.C.–(BUSINESS WIRE)–Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven Brands” or the “Company”) will release its first quarter... Read more.
Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer
Optune Lua is now approved for use concurrently with immune checkpoint inhibitors or docetaxel in adult patients with metastatic NSCLC who have progressed on or... Read more.
Circle Pharma to Present Late-Breaking Data at AACR 2025 Demonstrating Mechanism of Action for Novel Cyclin A/B RxL Inhibitors
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–#BreastCancer–Circle Pharma, a clinical-stage biopharmaceutical company focused on developing cell-permeable... Read more.
NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting
Additional Presentations Demonstrate Ongoing Commitment to Research & Innovation in Precision Oncology FORT MYERS, Fla.–(BUSINESS WIRE)–NeoGenomics,... Read more.